The efficacy of intravitreal ranibizumab for the treatment of macular oedema secondary to retinal vein occlusions in a treatment-naive cohort: 6-month outcomes

被引：0
|
作者：
Laginaf, Masara [1 ]
Lewis, Adam [1 ]
Chandran, Manju [1 ]
Menon, Geeta [1 ]
机构：
[1] Frimley Hlth NHS Fdn Trust, Ophthalmol, Frimley, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
204
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intravitreal aflibercept in routine clinical practice: 24-month results from the global treatment-naive cohort with macular edema secondary to central retinal vein occlusion in the AURIGA study
    Giocanti-Auregan, Audrey
    Yang, Chang-Hao
    Donati, Simone
    Allmeier, Helmut
    Machewitz, Tobias
    Rittenhouse, Kay D.
    Hoerauf, Hans
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [32] Safety and Efficacy of Two or More Dexamethasone Intravitreal Implants in Treatment-Naive Patients with Macular Edema Due to Retinal Vein Occlusion
    Singer, Michael
    Capone, Antonio
    Dugel, Pravin U.
    Dreyer, Richard F.
    Dodwell, David G.
    Roth, Daniel B.
    Shi, Rui
    Walt, John G.
    Scott, Lanita C.
    Hollander, David A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [33] Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population
    Gu, Xiaoya
    Yu, Xiaobing
    Song, Shuang
    Dai, Hong
    OPHTHALMIC RESEARCH, 2017, 58 (01) : 8 - 14
  • [34] Two-year outcomes of intravitreal (IVT) ranibizumab for macular oedema secondary to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO)
    Juma, Z.
    Tyagi, P.
    Santiago, C.
    Ionean, A.
    EYE, 2017, 31 : S16 - S16
  • [35] Comparison of Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab as a First-Line Treatment of Macular Oedema due to Retinal Vein Occlusion
    Mayer, W. J.
    Hadjigoli, A.
    Wolf, A.
    Herold, T.
    Haritoglou, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2015, 232 (11) : 1289 - 1296
  • [36] Retinal Vein Occlusions: Therapeutic Switch in Macular Oedema Treatment with a 12-Month Follow-Up
    Chiquet, Christophe
    Bron, Alain M.
    Straub, Morgane
    Dupuy, Caroline
    Isaico, Rodica
    Aptel, Florent
    Creuzot-Garcher, Catherine
    OPHTHALMIC RESEARCH, 2016, 55 (03) : 152 - 158
  • [37] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    Cheng, K-C
    Wu, W-C
    Chen, K-J
    EYE, 2009, 23 (11) : 2024 - 2032
  • [38] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    K-C Cheng
    W-C Wu
    K-J Chen
    Eye, 2009, 23 : 2023 - 2033
  • [39] Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion
    Spandau, Ulrich H. M.
    Ihloff, Anna K.
    Jonas, Jost B.
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (04): : 555 - 556
  • [40] Analysis of intravitreal bevacizumab treatment for macular oedema due to retinal vein occlusion
    Balla, Szabolcs
    Zold, Eszter
    Potor, Laszlo
    Lukucz, Balazs
    Vajas, Attila
    Ujhelyi, Bernadett
    Nagy, Valeria
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (05) : 2528 - 2534
12345